We are live on ! Find out more
WF

Welch & Forbes Portfolio holdings

AUM $8.23B
1-Year Est. Return 17.62%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$3.49B
AUM Growth
+$152M
Cap. Flow
-$14M
Cap. Flow %
-0.4%
Top 10 Hldgs %
22.41%
Holding
361
New
18
Increased
147
Reduced
147
Closed
14

Top Sells

Rank Stock Value
1
LLTC
Linear Technology Corp
LLTC
+$8.75M
2
AGN
Allergan plc
AGN
+$7.3M
3
AFL icon
Aflac
AFL
+$5.62M
4
GILD icon
Gilead Sciences
GILD
+$5.44M
5
ORCL icon
Oracle
ORCL
+$4.24M

Sector Composition

Rank Sector Weight
1 Healthcare 19.72%
2 Technology 15.24%
3 Industrials 10.94%
4 Financials 10.9%
5 Consumer Discretionary 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
76
Bank of America
BAC
$435B
$15.3M 0.44%
650,163
+18,111
+3% +$430K
BRK.B icon
77
Berkshire Hathaway Class B
BRK.B
$1.1T
$15.1M 0.43%
90,505
-1,339
-1% -$224K
BDX icon
78
Becton Dickinson
BDX
$45.6B
$14.3M 0.41%
79,988
-334
-0.4% -$58.2K
MZTI
79
The Marzetti Company
MZTI
$2.93B
$13.4M 0.38%
104,339
-536
-0.5% -$71.9K
CSCO icon
80
Cisco
CSCO
$457B
$13.3M 0.38%
393,445
+26,404
+7% +$856K
BMY icon
81
Bristol-Myers Squibb
BMY
$133B
$13.1M 0.38%
241,520
-43,296
-15% -$2.37M
PFF icon
82
iShares Preferred and Income Securities ETF
PFF
$13.3B
$12.9M 0.37%
334,424
+26,285
+9% +$1M
QCOM icon
83
Qualcomm
QCOM
$155B
$12.6M 0.36%
219,133
-37,781
-15% -$2.19M
LLY icon
84
Eli Lilly
LLY
$1.02T
$12.2M 0.35%
144,660
-660
-0.5% -$52.9K
GILD icon
85
Gilead Sciences
GILD
$162B
$11.5M 0.33%
169,238
-77,402
-31% -$5.44M
FTSL icon
86
First Trust Senior Loan Fund ETF
FTSL
$2.32B
$11.3M 0.32%
232,640
+31,160
+15% +$1.51M
EW icon
87
Edwards Lifesciences
EW
$49.6B
$10.7M 0.31%
341,631
-11,679
-3% -$366K
SU icon
88
Suncor Energy
SU
$79.4B
$10.7M 0.31%
347,274
-33,501
-9% -$1.06M
SYY icon
89
Sysco
SYY
$40.8B
$10.7M 0.3%
205,126
+4,476
+2% +$237K
EMR icon
90
Emerson Electric
EMR
$83.9B
$10.6M 0.3%
177,071
+4,176
+2% +$249K
BEN icon
91
Franklin Resources
BEN
$17.6B
$10.5M 0.3%
249,139
+185,714
+293% +$7.71M
BSX icon
92
Boston Scientific
BSX
$69.5B
$10M 0.29%
402,731
+61
+0% +$1.48K
CMI icon
93
Cummins
CMI
$87.5B
$9.5M 0.27%
62,822
+11,369
+22% +$1.68M
BIV icon
94
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$9.28M 0.27%
110,959
+127
+0.1% +$10.6K
HAIN icon
95
Hain Celestial
HAIN
$45M
$9.09M 0.26%
244,350
+2,710
+1% +$102K
SPY icon
96
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$9.09M 0.26%
38,537
+3,965
+11% +$921K
VEA icon
97
Vanguard FTSE Developed Markets ETF
VEA
$229B
$9.05M 0.26%
230,277
+41,360
+22% +$1.58M
UPS icon
98
United Parcel Service
UPS
$88.6B
$9.01M 0.26%
83,991
+715
+0.9% +$78.1K
WMT icon
99
Walmart Inc
WMT
$885B
$8.45M 0.24%
351,675
+5,556
+2% +$128K
BKLN icon
100
Invesco Senior Loan ETF
BKLN
$6.97B
$8.37M 0.24%
359,697
+25
+0% +$583

Similar funds

Welch & Forbes's Q1 2017 Portfolio in Review

As of Q1 2017, Welch & Forbes held 361 positions worth $3.49B, up 4.5% from $3.34B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Welch & Forbes's Q1 2017 filing shows 18 new, 147 increased, 147 reduced and 14 closed positions. Its largest new stake was iShares Russell 1000 Value ETF: 11,269 shares worth $1.3M. The largest sale was Linear Technology Corp, an estimated $8.75M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

  • Welch & Forbes's largest Q1 2017 buy was iShares Russell 1000 Value ETF: 11,269 shares worth $1.3M.
  • Welch & Forbes added most to Franklin Resources in Q1 2017, an estimated $7.71M increase.
  • Welch & Forbes's biggest Q1 2017 reduction was Aflac, cutting an estimated $5.62M.
  • Welch & Forbes fully exited Linear Technology Corp in Q1 2017, selling an estimated $8.75M.
  • Welch & Forbes's ten largest holdings make up 22% of its $3.49B portfolio in Q1 2017.
  • Welch & Forbes opened 18 new positions and closed 14 in Q1 2017.
  • Welch & Forbes's portfolio value rose 4.5% quarter-over-quarter to $3.49B.

Based on Welch & Forbes's 13F filing for Q1 2017, filed 27 Apr 2017.